Explore the full directors' dealings record of Oncopeptides AB, a listed issuer based in Finland. Shares are quoted on FI FI, under the oversight of FIN-FSA. Operating in the Healthcare sector, Oncopeptides AB has published 1 insider filings. Market capitalisation: €652.5m. The latest transaction was filed on 17 March 2026 — Purchase. Among the most active insiders: Sofia Heigis. All data is free.